AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*
